Pancreatic Cancer Research

ResearcherWright State UniversityNo recent work listed

Ravi P. Sahu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 9 November 2026

Matched on ORCID iD 0000-0003-3857-9073; OpenAlex author ID A5032644073. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: 2 papers · 2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper

Papers 7

  1. KRAS Pathway-based Therapeutic Approaches in Pancreatic Cancer. Last author DOI 10.2174/1389557523666221226095931↗
  2. Exploiting the relevance of CA 19-9 in pancreatic cancer. Last author DOI 10.20517/2394-4722.2020.70↗
  3. Dietary Polyphenols in Cancer Chemoprevention: Implications in Pancreatic Cancer. Last author DOI 10.3390/antiox9080651↗
  4. Exploring Signaling Pathways and Pancreatic Cancer Treatment Approaches Using Genetic Models. Last author DOI 10.2174/1389557519666190327163644↗
  5. Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches. Last author DOI 10.3390/cancers11111627↗
  6. Gemcitabine Induces Microvesicle Particle Release in a Platelet-Activating Factor-Receptor-Dependent Manner via Modulation of the MAPK Pathway in Pancreatic Ca… Last author DOI 10.3390/ijms20010032↗
  7. Natural Anti-Cancer Agents: Implications in Gemcitabine-Resistant Pancreatic Cancer Treatment. First author DOI 10.2174/1389557517666170315124438↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anita Thyagarajan-Sahu · 6 shared papers, 2018–2023 · strength 1.02
  2. Abdullah Althaiban · 1 shared paper, 2023 · strength 0.31
  3. Syaza Salleh · 1 shared paper, 2020 · strength 0.19
  4. S. T. Sheik Abdul Khader · 1 shared paper, 2019 · strength 0.16
  5. Bishal Marasini · 1 shared paper, 2017 · strength 0.15
  6. Catherine M.T. Sherwin · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.